Home Healthcare Pharmaceuticals Drug Delivery Technologies Market

Drug Delivery Technologies Market Size, Share & Trends Analysis Report By Technology (Targeted Drug Delivery, Sustained Release Technology, Controlled Release Drug Delivery, Polymeric Drug Delivery, Others), By Route of Administration (Oral, Nasal, Parenteral, Topical), By Application (Oncology, Respiratory Diseases, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 18, 2026 | Author: Debashree Bora | Format:

Drug Delivery Technologies Market Size & Growth Analysis

The global drug delivery technologies market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 2.15 billion in 2026 to USD 9.08 billion by 2034, registering a CAGR of 19.7% during the forecast period from 2026 to 2034. North America dominated the drug delivery technologies market with a market share of 38.4% in 2025.

Drug delivery technologies are systems and methods used to deliver medicines to specific areas of the body safely and effectively. They include oral, injectable, transdermal, inhalation, implantable, and targeted delivery systems designed to improve drug absorption, controlled release, patient convenience, and treatment outcomes.

Drug Delivery Technologies Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 1.8 Billion
2026 Market Size
USD 2.15 Billion
2034 Projected Market Size
USD 9.08 Billion
Forecast Period
2026–2034
Base Year
2025
Market CAGR (2026–2034)
19.7%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.4%
Fastest-Growing Region
Asia Pacific
Asia Pacific CAGR (2026–2034)
14.9%

Segment Insights

By Technology
Leading Segment
Targeted Drug Delivery
Market Share in 2025 29.6%
By Route of Administration
Fastest-Growing Segment
Parenteral
CAGR 14.1% (2026–2034)
By Application
Leading Segment
Oncology
Market Share in 2025 30.5%
By End-User
Fastest-Growing Segment
Ambulatory Surgical Centers
CAGR 13.8% (2026–2034)
Drug Delivery Technologies Market Size

Download a Free Sample To learn more about this report.

Drug Delivery Technologies Market Segmentation Analysis

By Technology

Targeted Drug Delivery Segment Dominated the Market with 29.6% Share in 2025

The targeted drug delivery segment dominated the drug delivery technologies market with a 29.6% share in 2025, reaching USD 0.53 billion, and is projected to grow at a CAGR of 14.2% during 2026–2034. Its leading position is supported by the ability to deliver medicines more precisely to specific tissues or cells while potentially reducing exposure to healthy areas. Growing interest in personalized therapies and advanced treatments is further supporting demand for targeted delivery approaches.

Sustained release and controlled release technologies help maintain drug concentrations over longer periods and can reduce the frequency of administration. Polymeric drug delivery systems are used to improve drug stability and control the release of active ingredients. Other technologies include specialized approaches designed to improve drug absorption, delivery efficiency, and patient convenience across different therapeutic applications.

Drug Delivery Technologies Market Size By Segments

Request Customizationto receive a tailored report.

By Route of Administration

Parenteral Segment is Projected to Grow at the Fastest CAGR of 14.1%

The parenteral segment accounted for a 32.6% share of the drug delivery technologies market in 2025, reaching USD 0.59 billion, and is projected to grow at the fastest CAGR of 14.1% during 2026–2034. Its growth is supported by the increasing use of injectable medicines for biologics, vaccines, oncology therapies, and other treatments where rapid or controlled delivery is required. Advances in injectable formulations and delivery devices are also improving treatment convenience.

Oral delivery remains widely used because of its convenience and familiarity among patients. Nasal delivery provides an alternative for certain drugs where rapid absorption or localized treatment is preferred. Topical delivery is commonly used for medicines applied directly to the skin and continues to serve dermatological and other localized treatment applications.

By Application

Oncology Segment Dominated the Market with 30.5% Share in 2025

The oncology segment dominated the drug delivery technologies market with a 30.5% share in 2025, reaching USD 0.55 billion, and is projected to grow at a CAGR of 14.6% during 2026–2034. Its leading position is linked to the growing development of targeted cancer therapies and the need for delivery systems that can improve treatment precision. Advanced delivery technologies are increasingly being explored to improve drug exposure at tumor sites while limiting unwanted effects.

Respiratory diseases use drug delivery technologies to support efficient administration through inhaled and other routes. Cardiovascular applications include delivery systems for medicines used to manage heart and vascular conditions. Autoimmune diseases benefit from sustained and targeted delivery approaches, while central nervous system applications are increasingly exploring specialized technologies that can improve drug delivery to difficult-to-reach areas. Other applications cover additional therapeutic conditions requiring improved delivery performance.

By End-User

Ambulatory Surgical Centers Segment is Projected to Grow at the Fastest CAGR of 13.8%

The ambulatory surgical centers segment accounted for a 22.4% share of the drug delivery technologies market in 2025, reaching USD 0.40 billion, and is projected to grow at the fastest CAGR of 13.8% during 2026–2034. Its growth is supported by the increasing number of outpatient procedures and the growing preference for shorter hospital stays. Drug delivery technologies can help healthcare professionals administer medicines efficiently during procedures and support recovery after treatment.

Hospitals remain important users of drug delivery technologies because they manage a wide range of acute and chronic conditions and require multiple delivery methods. Diagnostic centers use selected delivery technologies alongside procedures and diagnostic services. Other end-users include specialty clinics, research facilities, and healthcare organizations that require reliable drug administration solutions for specific treatment and patient-care needs.

Drug Delivery Technologies Market Share By Segments

Speak to an Analystto discuss market opportunities.

Drug Delivery Technologies Market Regional Outlook

North America Drug Delivery Technologies Market Analysis

North America drug delivery technologies market accounted for 38.4% of the global market, reaching USD 0.69 billion in 2025, and is projected to grow at a CAGR of 12.2% during the forecast period. Growth is supported by advanced healthcare infrastructure, strong pharmaceutical and biotechnology industries, increasing adoption of targeted therapies, and rising demand for self-administration and home healthcare solutions.

United States Drug Delivery Technologies Market Insights

The US market is the largest contributor to North America, supported by advanced pharmaceutical research, strong biotechnology capabilities, and increasing adoption of targeted and controlled-release drug delivery technologies. Growing demand for oncology and biologic therapies is further supporting market expansion.

Canada Drug Delivery Technologies Market Insights

Canada's market is supported by increasing healthcare investments, expanding pharmaceutical research, and growing adoption of advanced drug delivery systems. Rising demand for patient-friendly and convenient treatment options is creating additional growth opportunities.

North America Drug Delivery Technologies Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Drug Delivery Technologies Market Analysis

Europe drug delivery technologies market accounted for 27.1% of the global market, reaching USD 0.49 billion in 2025, and is projected to grow at a CAGR of 11.8% during the forecast period. Growth is driven by a strong pharmaceutical sector, increasing investment in drug development, and rising adoption of advanced delivery technologies. Growing demand for targeted and personalized therapies is also supporting regional expansion.

United Kingdom Drug Delivery Technologies Market Insights

The UK market is supported by strong pharmaceutical research capabilities, advanced healthcare infrastructure, and increasing adoption of innovative drug delivery systems. Growing development of biologics and targeted therapies is further supporting market growth.

Germany Drug Delivery Technologies Market Insights

Germany's market is driven by its established pharmaceutical industry, advanced research capabilities, and growing adoption of controlled and targeted drug delivery technologies. Increasing investment in complex therapies is also supporting market expansion.

Asia Pacific Drug Delivery Technologies Market Analysis

Asia Pacific drug delivery technologies market accounted for 23.6% of the global market, reaching USD 0.42 billion in 2025, and is projected to register the fastest CAGR of 14.9% during the forecast period. Rapid pharmaceutical industry development, increasing healthcare expenditure, expanding healthcare infrastructure, and rising demand for advanced treatments are driving regional growth. China and Japan are among the important markets supporting regional expansion.

Japan Drug Delivery Technologies Market Insights

Japan's market is supported by advanced pharmaceutical research, an aging population, and increasing demand for convenient and targeted drug delivery systems. Growing adoption of innovative therapies is supporting continued market development.

China Drug Delivery Technologies Market Insights

China's market is driven by expanding pharmaceutical manufacturing, increasing research and development activities, and rising adoption of advanced drug delivery technologies. Growing healthcare expenditure and demand for therapies for chronic diseases are further supporting market growth.

Middle East and Africa Drug Delivery Technologies Market Analysis

Middle East and Africa drug delivery technologies market accounted for 4.7% of the global market, reaching USD 0.08 billion in 2025, and is projected to grow at a CAGR of 9.8% during the forecast period. Increasing healthcare investments, improving medical infrastructure, and growing access to advanced medicines are supporting regional market expansion.

UAE Drug Delivery Technologies Market Insights

The UAE market is supported by healthcare infrastructure development, increasing adoption of advanced medical technologies, and growing pharmaceutical investments. Rising demand for innovative and patient-friendly drug delivery systems is creating further opportunities.

Africa Drug Delivery Technologies Market Insights

Africa's market is supported by improving healthcare access, expanding pharmaceutical activities, and increasing investments in healthcare infrastructure. Growing demand for effective and convenient drug administration technologies is expected to support long-term market development.

List of Key and Emerging Players in Drug Delivery Technologies Market

Arbutus Biopharma
Camurus AB
ConjuChem, LLC
InnoCore Pharmaceuticals
Latitude Pharmaceuticals Inc.
Johnson & Johnson Services, Inc.
Hoffmann-La Roche Ltd
Merck & Co., Inc.
Bayer AG
Pfizer, Inc
Novartis AG
BD
Kindeva
Lindy Biosciences, Inc
NanoSyrinx Ltd

Key Industry Developments

June 2026
SHL Medical acquired Copernicus, expanding its capabilities in connected drug delivery systems and digital health solutions for injectable therapies.
May 2026
Gerresheimer completed the acquisition of Bormioli Pharma, strengthening its portfolio of pharmaceutical containment and drug delivery solutions.
September 2025
West Pharmaceutical Services launched the Daikyo PLASCAP® Ready-to-Use Validated (RUV) closure system, expanding its advanced containment and drug delivery technologies portfolio.
June 2025
Kindeva Drug Delivery completed the acquisition of Summit Biosciences, strengthening its intranasal drug delivery capabilities and expanding its contract development and manufacturing services.

Report Scope

Segmentation

By Technology 5
  • Targeted Drug Delivery
  • Sustained Release Technology
  • Controlled Release Drug Delivery
  • Polymeric Drug Delivery
  • Others
By Route of Administration 4
  • Oral
  • Nasal
  • Parenteral
  • Topical
By Application 6
  • Oncology
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others
By End-User 4
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Arbutus Biopharma · Camurus AB · ConjuChem, LLC · InnoCore Pharmaceuticals · Latitude Pharmaceuticals Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The drug delivery technologies market size is valued at USD 2.15 Billion in 2026 and is projected to reach USD 9.08 Billion by 2034, at a CAGR of 19.7% during the forecast period 2026-2034.

North America dominated the market with a share of 38.4% in 2025.

The leading players in this market are Arbutus Biopharma, Camurus AB, ConjuChem, LLC, InnoCore Pharmaceuticals.

The drug delivery technologies market is projected to grow at a CAGR of 19.7% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: